Nexstim Oyj

NXTMH · Nasdaq Helsinki · Healthcare

9.40EUR −0.7%last day

Price as of 2 October 2026

The price over the past year, with dividends: −25.7%

Performance

1 month

−5.8%

1 year

−25.7%

3 years, per year

+48.2%

5 years, per year

+15.9%

Largest fall, 3 years

−72.7%

Below the peak now

−98.7%

Volatility, 1 year

46.9%

Return with dividends reinvested.

Key figures

P/E

940.0

P/B

7.9

Dividend yield

0.0%

Return on equity

+0.6%

Net margin

+0.4%

Market value

76 m USD

Quality, value and trend

Where Nexstim stands against every Nordic stock today. 100 is best.

Quality45

Profitability and a sound balance sheet over time. Better than 45% of Nordic stocks.

Value10

The price measured against earnings, assets and cash flow. Better than 10% of Nordic stocks.

Trend39

The price development over the past year. Better than 39% of Nordic stocks.

Combined15

Quality, value and trend together. Better than 15% of Nordic stocks.

About Nexstim

Nexstim Oyj is a company in healthcare, listed on Nasdaq Helsinki. The share trades in EUR. It has around 44 employees.

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company offers non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS), including Navigated Brain Stimulation (NBS) system 6 for presurgical mapping of the speech and motor cortices of the brain, for the treatment of major depression and chronic unilateral neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb. The company markets and sells its diagnostics systems to universities and teaching hospitals.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis